NAD Therapy for Improving Memory and Brain Blood Flow in Older Adults With Mild Cognitive Impairment

Clinical trial NCT03482167 · COMPLETED

Trial details

NCT number: NCT03482167
Sponsor: University of Delaware
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Mild Cognitive Impairment

Start date: 2019-03-20
Primary completion: 2024-01-08
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.